People who have the APOE2 version of a gene called apolipoprotein E tend to live longer and get Alzheimer’s less often.
New research from the Buck Institute shows why. The study says APOE2 helps brain cells keep their DNA safe and stop becoming old and broken.
Three Gene Versions
The gene comes in three common forms: APOE2, APOE3 and APOE4. They differ by only two building blocks, but they act very differently.
APOE4 raises the chance of late‑onset Alzheimer’s. APOE2, on the other hand, is linked to a longer life and lower dementia risk.
How Scientists Tested the Genes
Researchers made human stem cells that were identical except for the APOE gene. They turned the cells into two types of neurons: inhibitory GABA‑ergic and excitatory glutamatergic.
They also looked at brain tissue from older mice that carried each human gene version.
APOE2 Reduces DNA Damage
Neurons with APOE2 showed less DNA breakage. Tests that read gene activity showed that APOE2 GABA‑ergic cells turned on many DNA‑repair pathways. APOE4 cells showed patterns linked to Alzheimer’s.
Less Cellular Aging
When the scientists stressed the neurons with radiation or a chemotherapy drug, APOE2 cells showed lower levels of aging markers such as p16 and CRYAB. Their nuclei stayed small and well organized.
Sharing the Protection
Adding purified APOE2 protein to APOE4 neurons lowered DNA‑damage signals after radiation. This hints that the protective effect can be passed to other cells.
Mouse Brain Findings
Older mice with APOE2 also had smaller nucleoli, more Lamin A/C protein, and tighter DNA packing in the hippocampus – signs of healthier brain aging.
What This Means
The work links APOE2 to two big aging problems: DNA damage and cellular senescence. It suggests that fixing DNA or removing old cells could give some of APOE2’s benefits to people with the risky APOE4 version.
Future Directions
Scientists still need to learn how APOE2 protects the cell nucleus and boosts repair. Future drugs that copy APOE2 or improve DNA repair may help those at high Alzheimer’s risk.